Trial Shows RA Can Be Stopped at Preclinical Stage
(MedPage Today) -- MILAN -- One year of treatment with abatacept (Orencia) kept "preclinical" rheumatoid arthritis (RA) from becoming clinical in most patients showing signs of imminent onset, a researcher reported here.
In a phase IIb randomized... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - June 1, 2023 Category: Primary Care Source Type: news
Beverage Consumption and Risk of Rheumatoid Arthritis Beverage Consumption and Risk of Rheumatoid Arthritis
The consumption of certain beverages may be linked to a greater risk for developing rheumatoid arthritis.Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 1, 2023 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news
TREMFYA ® (guselkumab) Provides Sustained Improvements Across All Minimal Disease Activity Domains for Adults Living with Active Psoriatic Arthritis in Phase 3b Trial
SPRING HOUSE, PENNSYLVANIA, May 31, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from the Phase 3b COSMOS clinical trial showing that treatment with TREMFYA® (guselkumab) provided sustainable improvements in all minimal disease activity (MDA)a domains through week 48 in adults living with active psoriatic arthritis (PsA) who previously had an inadequate response to one to two tumor necrosis factor inhibitors (TNFi-IR).[1] In a separate post-hoc analysis of the Phase 3 DISCOVER-1 and DISCOVER-2b clinical trial findings, TREMFYA was shown to be associated with prompt and su...
Source: Johnson and Johnson - May 31, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Increased risk of periodontitis in patients with rheumatoid arthritis: A nationwide register study in Norway
Conclusions:
In this register-based study in which periodontal treatment was
used as a surrogate marker for periodontitis, we found an increased risk
of periodontitis in RA patients, particularly those with active disease
and new RA. (Source: Dental Technology Blog)
Source: Dental Technology Blog - May 25, 2023 Category: Dentistry Source Type: news
Consumer Health: Treating arthritis
May is Arthritis Awareness Month, which makes this a good time to learn more about a condition that affects nearly 59 million people in the U.S., or approximately 1 in 4 adults. Arthritis is the swelling and tenderness of one or more of your joints. The main symptoms of arthritis are joint pain and stiffness, which typically worsen with age. The two most common types of arthritis — osteoarthritis and rheumatoid arthritis — damage joints in different… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - May 22, 2023 Category: Databases & Libraries Source Type: news
Drug May Offer New Approach Against Rheumatoid Arthritis
THURSDAY, May 18, 2023 -- An investigational drug may hit the reset button on a faulty immune system for some people with rheumatoid arthritis.
Rheumatoid arthritis, or RA, is an autoimmune disease that occurs when the body misfires against its own... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 18, 2023 Category: General Medicine Source Type: news
Investigational Drug Peresolimab May Offer New Approach Against Rheumatoid Arthritis
THURSDAY, May 18, 2023 -- An investigational drug may hit the reset button on a faulty immune system for some people with rheumatoid arthritis.
Rheumatoid arthritis, or RA, is an autoimmune disease that occurs when the body misfires against its own... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 18, 2023 Category: General Medicine Source Type: news
Janssen to Highlight Scientific Advances and Commitment to Transform Cancer Care at ASCO and EHA with More than 90 Presentations Showcasing Robust, Differentiated Portfolio and Pipeline in Hematologic Malignancies and Solid Tumors
This study evaluates an investigational combination regimen of IMBRUVICA® (ibrutinib) plus venetoclax (I+V) for newly diagnosed chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), (Abstracts #7535 and #P617, respectively).Advancing the Science of Solid Tumors Through Precision MedicineJanssen’s continued innovation in solid tumors focuses on advancing precision medicine options for patients with biomarker-driven disease who have limited targeted treatment options and moving patients into earlier lines of therapy when treatments may be more effective. Lung CancerAn oral presentation will report ...
Source: Johnson and Johnson - May 18, 2023 Category: Pharmaceuticals Tags: Innovation Source Type: news
Peresolimab Found to Be Efficacious for Rheumatoid Arthritis
THURSDAY, May 18, 2023 -- Peresolimab, a humanized immunoglobulin G1 monoclonal antibody designed to stimulate the endogenous programmed cell death protein 1 (PD-1) inhibitory pathway, is efficacious for patients with rheumatoid arthritis, according... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 18, 2023 Category: Pharmaceuticals Source Type: news
LYNK's LNK01001 Achieved Exciting Phase II Results in Rheumatoid Arthritis
HANGZHOU, China, May 16, 2023. Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as ' Lynk Pharmaceuticals ' ), an innovative clinical stage company, announced that the Phase II clinical trial of LNK01001 in the treatment of rheumatoid arthritis... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 16, 2023 Category: Pharmaceuticals Source Type: news
Rheumatoid Arthritis Linked to Increased Parkinson's Risk Rheumatoid Arthritis Linked to Increased Parkinson's Risk
A large prospective study shows that RA is linked to a twofold increased risk for Parkinson ' s disease, in new findings that suggest motor symptoms in this population should be thoroughly investigated by a neurologist.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - May 11, 2023 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Polycyclic Aromatic Hydrocarbons Linked to Rheumatoid Arthritis
WEDNESDAY, May 10, 2023 -- Polycyclic aromatic hydrocarbons (PAHs) are associated with rheumatoid arthritis (RA), according to a study published online May 9 in BMJ Open.
Michelle Beidelschies, Ph.D., from the Cleveland Clinic, and colleagues... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 10, 2023 Category: Pharmaceuticals Source Type: news
Toxins From Grilling, Smoking & Car Exhaust Could Raise Odds for Rheumatoid Arthritis
WEDNESDAY, May 10, 2023 -- Toxic chemicals that develop from car exhaust, smoking and backyard grilling might increase your risk of developing the autoimmune disease rheumatoid arthritis, a new study suggests.
These chemicals are called polycyclic... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 10, 2023 Category: General Medicine Source Type: news
Autoimmune disease increase linked to lifestyle risk factors
A study of over 22 million people has found that autoimmune diseases now affect around one in 10 individuals and could, in some instances, be driven by environmental factors. Some 19 of the most common autoimmune diseases, such as type 1 diabetes, rheumatoid arthritis and multiple sclerosis, have been shown to affect 13% of women... Read moreThe post Autoimmune disease increase linked to lifestyle risk factors appeared first on Nursing in Practice. (Source: Nursing in Practice)
Source: Nursing in Practice - May 10, 2023 Category: Nursing Authors: Megan Ford Tags: Clinical Diabetes Musculoskeletal Source Type: news
Barbecues could cause rheumatoid arthritis, according to a new study
New research has linked breathing in certain fumes to the development of rheumatoid arthritis. (Source: Daily Express - Health)
Source: Daily Express - Health - May 9, 2023 Category: Consumer Health News Source Type: news
